https://www.fda.gov/drugs/drug-safety-and-availability/fda-updates-guidance-interchangeability?utm_medium=email&utm_source=govdelivery
This draft guidance describes considerations regarding a switching study or studies intended to support a demonstration that a biological product is interchangeable with a reference product.
No hay comentarios:
Publicar un comentario